Abbott wins FDA panel vote for mitral valve repair system

03/21/2013 | Yahoo

A panel of FDA advisers has voted in favor of recommending approval for Abbott Laboratories' MitraClip system, saying its benefits surpassed the risks. The implantable device, available commercially in 30 countries, is used to treat leaky mitral heart valves in patients who are deemed at high risk for open-heart procedures.

View Full Article in:

Yahoo

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC